TLN1
Description
The TLN1 (talin 1) is a protein-coding gene located on chromosome 9.
Talin-1 is a protein that in humans is encoded by the TLN1 gene. Talin-1 is ubiquitously expressed, and is localized to costamere structures in cardiac and skeletal muscle cells, and to focal adhesions in smooth muscle and non-muscle cells. Talin-1 functions to mediate cell-cell adhesion via the linkage of integrins to the actin cytoskeleton and in the activation of integrins. Altered expression of talin-1 has been observed in patients with heart failure, however no mutations in TLN1 have been linked with specific diseases.
== Structure == Human talin-1 is 270.0 kDa molecular weight and 2541 amino acids. The N-terminal region of talin-1 is ~50 kDa in size and homologous to members of the ERM protein family which have a globular FERM domain (residues 86-400) that links the actin cytoskeleton to adhesion proteins. In addition to F-actin, the N-terminal region of talin-1 binds layilin, β1- and β3-integrin, and focal adhesion kinase. Talin-1 N-terminal region also binds acidic phospholipids for insertion into lipid bilayers. The rod domain (>200 kDa) has considerable flexibility and houses a conserved actin binding site, three vinculin binding sites, and also has an additional integrin binding site, termed IBS2. The head and rod domains are connected by an unstructured linker region (residues 401-481), which houses several sites of phosphorylation, as well as protease cleavage.
Talin-1 is a high molecular weight cytoskeletal protein that plays a crucial role in connecting major cytoskeletal structures to the plasma membrane. It is concentrated at regions of cell-substratum contact and, in lymphocytes, at cell-cell contacts.
TLN1 is also known as ILWEQ, TLN, talin-1.
Associated Diseases
- cancer
- Noonan syndrome
- Costello syndrome
- cardiofaciocutaneous syndrome
- thyroid gland adenocarcinoma
- endometrial cancer
- esophageal cancer